Search clinical trials for: Chimeric Antigen Receptor T cells
Total 498434 results
-
Baylor College of MedicineCancer Prevention Research Institute of Texas; The Methodist Hospital Research... and other collaboratorsActive, not recruiting
-
Bioray LaboratoriesFirst Affiliated Hospital of Zhejiang UniversityCompleted
-
Juno Therapeutics, a Subsidiary of CelgeneCompletedLymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Lymphoma, NonhodgkinUnited States
-
Shanghai General Hospital, Shanghai Jiao Tong University...CompletedAcute Lymphoblastic Leukemia | MRD-positiveChina
-
Takara Bio Inc.Active, not recruitingLymphoblastic Leukemia, Acute AdultJapan
-
Juno Therapeutics, a Subsidiary of CelgeneBristol-Myers SquibbCompletedNeoplasms | Neoplasms by Histologic Type | Lymphoma | Lymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoproliferative Disorders | Lymphatic Diseases | Immunoproliferative Disorders | Lymphoma, Non-Hodgkin | Immune System DisorderUnited States
-
Baylor College of MedicineCancer Prevention Research Institute of Texas; The Methodist Hospital Research... and other collaboratorsActive, not recruitingRefractory Neuroblastoma | Uveal Melanoma | Relapsed Ewing Sarcoma | Relapsed Osteosarcoma | Relapsed Neuroblastoma | Relapsed Rhabdomyosarcoma | Phyllodes Breast TumorUnited States
-
Shanghai Ming Ju Biotechnology Co., Ltd.CompletedDiffuse Large B Cell LymphomaChina
-
Benjamin TomlinsonActive, not recruitingNon-Hodgkin LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingMyeloma-Multiple | Myeloma, Plasma-CellUnited States
-
Myeloid TherapeuticsSuspendedLymphoma, T-Cell, Cutaneous | Mycosis Fungoides | Lymphoma, T-Cell, Peripheral | Cell Therapy | Adoptive Cellular ImmunotherapyUnited States
-
Dartmouth-Hitchcock Medical CenterCompletedMyelodysplastic Syndromes | Leukemia, Myeloid | Multiple Myeloma | Lymphoma, Malignant | Myelofibrosis | Waldenstrom Macroglobulinemia | Leukemia, LymphoidUnited States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...Active, not recruitingNon-Hodgkin's Lymphoma | B-Cell ALL | B-Cell CLLUnited States
-
Legend Biotech USA IncActive, not recruitingT-Cell Lymphoma | Peripheral T-Cell Lymphoma Refractory | Cutaneous T-Cell Lymphoma Refractory | Cutaneous T-Cell Lymphoma Recurrent | Peripheral T-Cell Lymphoma RecurrentUnited States
-
Baylor College of MedicineThe Methodist Hospital Research InstituteWithdrawnClassical Hodgkin Lymphoma | Extranodal Natural Killer/T-Cell Lymphoma, Nasal TypeUnited States
-
Medical College of WisconsinMiltenyi Biomedicine GmbHActive, not recruitingB-cell Chronic Lymphocytic Leukemia | B-cell Non Hodgkin LymphomaUnited States
-
St. Jude Children's Research HospitalActive, not recruitingAcute Lymphoblastic Leukemia, in Relapse | Acute Lymphoblastic Leukemia, RefractoryUnited States
-
Memorial Sloan Kettering Cancer CenterTakedaActive, not recruitingWaldenstrom Macroglobulinemia | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B Cell Lymphoma | Burkitt's Lymphoma | Primary Mediastinal Large B Cell Lymphoma | Indolent Non-Hodgkin Lymphoma | Primary CNS Lymphoma | Transformed Follicular Lymphoma to Diffuse Large B Cell LymphomaUnited States
-
Tceleron Therapeutics, Inc.TerminatedMetastatic Castration-resistant Prostate CancerUnited States
-
University of California, San FranciscoCompletedRefractory Plasma Cell Myeloma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Plasma Cell Myeloma | Recurrent Malignant Neoplasm | Refractory Malignant Neoplasm | Recurrent High Grade B-Cell Lymphoma | Refractory High Grade B-Cell Lymphoma | Recurrent... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnProgressive Disease | Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Refractory Chronic Lymphocytic Leukemia | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Minimal Residual Disease | Recurrent Chronic Lymphocytic Leukemia | CD19 Positive | CD22...United States
-
Tceleron Therapeutics, Inc.TerminatedMetastatic Castration-resistant Prostate CancerUnited States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...Active, not recruitingBrain Tumor, Recurrent | Brain Tumor, RefractoryUnited States
-
Medical College of WisconsinChildren's Hospital and Health System Foundation, WisconsinCompletedLymphoma, B-Cell | Lymphoma, Non-Hodgkin | Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingMultiple MyelomaUnited States
-
University of Colorado, DenverReimagine CareActive, not recruiting
-
Zhejiang UniversityBioray LaboratoriesCompletedCastrate-Resistant Prostate CancerChina
-
Weijia Fang, MDNanjing Blue Shield Biotech Co.,LtdCompleted
-
Memorial Sloan Kettering Cancer CenterUnited States Department of DefenseActive, not recruitingBreast Cancer | Metastatic HER2-negative BreastUnited States
-
University of PennsylvaniaWithdrawnAcute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma
-
University of PennsylvaniaTerminatedRelapsed or Refractory B-cell Acute Lymphoblastic LeukemiaUnited States
-
University of PennsylvaniaTerminatedLYMPHOCYTIC LEUKEMIA (CLL) OR SMALL LYMPHOCYTIC LYMPHOMA (SLL)United States
-
University of PennsylvaniaUniversity of California, San FranciscoTerminatedPatients With Residual or Reccurent EGFRvIII+ GliomaUnited States
-
Pack HealthNovartis; Ohio State University Comprehensive Cancer CenterTerminatedLymphoma, Large B-Cell, DiffuseUnited States
-
University College, LondonCompletedDiffuse Large B-Cell LymphomaUnited Kingdom
-
Bellicum PharmaceuticalsSuspendedHER2-positive Breast Cancer | HER2-positive Gastric Cancer | Solid Tumor, Adult | HER-2 Gene Amplification | HER-2 Protein OverexpressionUnited States
-
National Cancer Institute (NCI)CompletedT Cells Expressing a Fully-human AntiCD19 Chimeric Antigen Receptor for Treating B-cell MalignanciesLymphoma, B-Cell | Lymphoma, Non-hodgkinsUnited States
-
Groupe Hospitalier Pitie-SalpetriereCompletedCancer | Adverse Drug ReactionsFrance
-
Juno Therapeutics, a Subsidiary of CelgeneActive, not recruiting
-
Federal Research Institute of Pediatric Hematology...Active, not recruitingB-cell Acute Lymphoblastic Leukemia | Acute Lymphocytic Leukemia, PediatricRussian Federation
-
Second Affiliated Hospital, School of Medicine,...Enrolling by invitationDiffuse Large B-cell LymphomaChina
-
Baylor College of MedicineCancer Prevention Research Institute of Texas; The Methodist Hospital Research... and other collaboratorsCompletedHepatocellular CarcinomaUnited States
-
Zhejiang UniversityCARsgen Therapeutics Co., Ltd.CompletedAdvanced Hepatocellular CarcinomaChina
-
National Cancer Institute (NCI)CompletedLymphoma, Large B-Cell, Diffuse | Lymphoma, T-Cell, Peripheral | Lymphoma, Large-Cell, Anaplastic | Lymphoma, Extranodal NK-T-Cell | Enteropathy-Associated T-Cell LymphomaUnited States
-
Loyola UniversityLeukemia Research FoundationActive, not recruitingB-Cell Acute Lymphoblastic Leukemia, Adult | B-cell Lymphoma Refractory | B-cell Lymphoma RecurrentUnited States
-
Institute of Hematology & Blood Diseases HospitalJuventas Cell Therapy Ltd.Active, not recruitingRelapsed or Refractory B Cell Acute Lymphoblastic LeukemiaChina
-
Juno Therapeutics, a Subsidiary of CelgeneCompletedAcute Lymphoblastic LeukemiaUnited States
-
Peter MacCallum Cancer Centre, AustraliaCompleted
-
Memorial Sloan Kettering Cancer CenterWithdrawnLymphoma | Lymphoma, B-Cell | LeukemiaUnited States
-
CARsgen Therapeutics Co., Ltd.RenJi Hospital; First Affiliated Hospital of Zhejiang University; NanJing PLA...Completed